Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293824 · ClinicalTrials.gov registry record
Effect of Feedings on Caffeine in Premature Infants
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 50
- Enrollment target
NCT02293824: Completed study, sponsored by Duke University.
NCT02293824 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02293824 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Almost all infants born \<29 weeks gestational age develop apnea of prematurity and are treated with caffeine. Type of diet and disease states may be significant contributors of variability in caffeine metabolism and pharmacokinetics (PK) in this population. This prospective, observational, open-label, opportunistic PK study will compare the population PK of caffeine between infants fed formula and infants fed exclusively breast milk; compare the activities of caffeine metabolizing enzymes between infants fed formula and infants fed exclusively breast milk; and determine the effect of hypoxia, hypotension, and infection on caffeine PK and metabolism in premature infants.
Primary Outcome
Using population pharmacokinetic analyses
Interventions
- DRUG Caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-06-30 |
What the finished NCT02293824 record still lists
NCT02293824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Caffeine is the first listed.
NCT02293824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02293824 about?
NCT02293824 is a clinical study titled "Effect of Feedings on Caffeine in Premature Infants". Almost all infants born \<29 weeks gestational age develop apnea of prematurity and are treated with caffeine. Type of diet and disease states may be significant contributors of variability in caffeine metabolism and pharmacokinetics (PK) in this population. This prospective, observational, open-lab...
What is the current status of trial NCT02293824?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-12. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02293824?
The interventions under investigation include: Caffeine (DRUG).
Who is sponsoring clinical trial NCT02293824?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia